[
  {
    "filename": "trial_inflammation_uk.txt",
    "country": "United Kingdom",
    "topic": "Inflammatory Diseases",
    "source_type": "Clinical Trial Report",
    "pages": [
      {
        "page_number": 1,
        "title": "IL-6 Inhibition Trial – Phase II Study",
        "keywords": ["Liximab", "IL-6", "Rheumatoid Arthritis", "Inflammation", "Oxford"],
        "main_investigator": "Dr. Amelia Wright",
        "institution": "University of Oxford",
        "year": 2024
      },
      {
        "page_number": 2,
        "title": "Biomarker Analysis and Future Directions",
        "keywords": ["Biomarkers", "IL-6", "TNF-alpha", "AstraZeneca", "UK-MHRA"],
        "main_investigator": "Dr. Amelia Wright",
        "institution": "University of Oxford",
        "year": 2024
      }
    ]
  },
  {
    "filename": "oncology_update_spain.txt",
    "country": "Spain",
    "topic": "Oncology",
    "source_type": "Congress Summary",
    "pages": [
      {
        "page_number": 1,
        "title": "ESMO 2024: Advances in EGFR Inhibition",
        "keywords": ["AZD5478", "EGFR", "NSCLC", "AstraZeneca", "ESMO"],
        "main_investigator": "Dr. Isabel Romero",
        "institution": "Hospital Vall d’Hebron",
        "year": 2024
      },
      {
        "page_number": 2,
        "title": "Combination Therapies in Triple-Negative Breast Cancer",
        "keywords": ["Pembrolizumab", "Sacituzumab Govitecan", "TNBC", "GEICAM", "Immunotherapy"],
        "main_investigator": "Dr. Laura Sánchez",
        "institution": "Hospital 12 de Octubre",
        "year": 2024
      },
      {
        "page_number": 3,
        "title": "The OncoDataLink Initiative",
        "keywords": ["Data Integration", "OncoDataLink", "Genomics", "AI", "Real-World Evidence"],
        "main_investigator": "Dr. Isabel Romero",
        "institution": "RedOnco Network",
        "year": 2024
      }
    ]
  },
  {
    "filename": "cardio_study_usa.txt",
    "country": "USA",
    "topic": "Cardiology",
    "source_type": "Publication Abstracts",
    "pages": [
      {
        "page_number": 1,
        "title": "CARDI-RED: Non-Statin LDL Reduction Strategies",
        "keywords": ["Bempedoic Acid", "Ezetimibe", "LDL", "Mayo Clinic", "Cleveland Heart Center"],
        "main_investigator": "Dr. Michael Nguyen",
        "institution": "Mayo Clinic",
        "year": 2024
      },
      {
        "page_number": 2,
        "title": "Pharmacogenomic Insights and Future Directions",
        "keywords": ["PCSK9", "Genotyping", "Pharmacogenomics", "FDA", "Cardiovascular Risk"],
        "main_investigator": "Dr. Michael Nguyen",
        "institution": "Mayo Clinic",
        "year": 2024
      }
    ]
  }
]
